MedTrace Logo

Omega-3 Fatty Acids for Treating Adults With Major Depression

NCT00517036 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2013-04-04

No results posted yet for this study

Summary

This study will test the effectiveness of two different kinds of omega-3 fatty acid dietary supplements in treating the symptoms of major depression.

Conditions

Interventions

DIETARY_SUPPLEMENT

EPA omega-3 fatty acid

1 gram per day of an EPA-enriched mixture for 8 weeks

DIETARY_SUPPLEMENT

DHA omega-3 fatty acid

1 gram per day of pure DHA for 8 weeks

DIETARY_SUPPLEMENT

Placebo comparator

1 gram per day of an inactive substance for 8 weeks

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Massachusetts General Hospital

    collaborator OTHER

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Mark H. Rapaport, MD · Emory University

  • David Mischoulon, MD, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00517036 on ClinicalTrials.gov